Evolent Health, Inc. (EVH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Remitly Global, Inc.

Progyny, Inc.

Grand Canyon Education, Inc.

MAXIMUS, Inc.

ADT, Inc.

Clarivate Plc

Bright Horizons Family Solutions, Inc.

The Brink's Co.

Concentrix Corp.

Shift4 Payments, Inc.

Evolent Health, Inc.

Why is Evolent Health, Inc. ?

Poor Management Efficiency with a low ROCE of 0.44%

The company has been able to generate a Return on Capital Employed (avg) of 0.44% signifying low profitability per unit of total capital (equity and debt)

The company has declared negative results for the last 3 consecutive quarters

PRE-TAX PROFIT(Q) At USD -7.73 MM has Fallen at -355.12%
NET PROFIT(Q) At USD -6.9 MM has Fallen at -311.27%
OPERATING CASH FLOW(Y) Lowest at USD -33.32 MM

Risky - Negative Operating Profits

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -67.03%, its profits have fallen by -7350%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -67.03% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Evolent Health, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Evolent Health, Inc.

-52.64%

-1.23

67.61%

S&P 500

20.78%

0.70

20.15%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.91%

EBIT Growth (5y)

13.32%

EBIT to Interest (avg)

-0.03

Debt to EBITDA (avg)

3.44

Net Debt to Equity (avg)

0.84

Sales to Capital Employed (avg)

1.19

Tax Ratio

0.46%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

0.44%

ROE (avg)

1.93%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.60

EV to EBIT

-237.65

EV to EBITDA

8.95

EV to Capital Employed

0.86

EV to Sales

0.56

PEG Ratio

Dividend Yield

ROCE (Latest)

-0.36%

ROE (Latest)

-22.80%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

NET SALES(Q)

Highest at USD 496.25 MM

PRE-TAX PROFIT(Q)

At USD -25.26 MM has Grown at 57.77%

NET PROFIT(Q)

At USD -26.17 MM has Grown at 57.3%

-23What is not working for the Company

INTEREST(HY)

At USD 35.88 MM has Grown at 109.75%

NET SALES(HY)

At USD 964.96 MM has Grown at -14.62%

ROCE(HY)

Lowest at -74.56%

DEBT-EQUITY RATIO (HY)

Highest at 206.72 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.07 times

INTEREST COVERAGE RATIO(Q)

Lowest at 73.21

RAW MATERIAL COST(Y)

Grown by 24.32% (YoY

CASH AND EQV(HY)

Lowest at USD 344 MM

OPERATING PROFIT(Q)

Lowest at USD 12.35 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 2.49 %

Here's what is working for Evolent Health, Inc.

Net Sales

Highest at USD 496.25 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Pre-Tax Profit

At USD -25.26 MM has Grown at 57.77%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

At USD -26.17 MM has Grown at 57.3%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Here's what is not working for Evolent Health, Inc.

Interest

At USD 35.88 MM has Grown at 109.75%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest Coverage Ratio

Lowest at 73.21

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at 206.72 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 5.07 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Operating Profit

Lowest at USD 12.35 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin

Lowest at 2.49 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Cash and Eqv

Lowest at USD 344 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost

Grown by 24.32% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales